Phase II Trial of Low-Dose Methotrexate and Iodine I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Iodine-131 tositumomab (Primary) ; Methotrexate
- Indications Follicular lymphoma
- Focus Adverse reactions
- 20 Jun 2016 Status changed from suspended to discontinued as Bexxar isn't being produced by the manufacturer as of Feb. 2014
- 03 Oct 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
- 04 Jun 2013 15 patients were enrolled between August 2011 and October 2012, according to ASCO 2013 abstract.